Administrative: The Cancer Center Support Grant is administered by the Koch Institute for Integrative Cancer Research at MIT under the direction of Ms. Cynthia Quense, the Assistant Director for Administration. The Koch Institute has a centralized administrative system to support the Members within the Koch Institute building. This structure allows for specialization within areas while also providing administrative staff that are very familiar with the individualized needs of Members and their respective laboratories. The central administration team (known as the Headquarters Office (HQ)) provides support to the Koch Institute in the following key areas: Finance, pre and post award of research and discretionary funds; Human Resources; Operations (Facilities & Building Maintenance); Program and Grant Administration; Reception/Office Management, and; Koch Institute Events including Symposium, Retreat and Special Seminars. Coordination and oversight is also provided to research administration areas including Environment, Health, and Safety (EHS), financial oversight of Core Facilities and Faculty Administrative Assistants. In addition, the HQ team provides CCSG-specific administrative support to the Members outside of the building in the areas of: Core Facilities operations and billing, Membership, Program support, Pilot Projects, other internal funding mechanisms, funding announcements, cancer-related fellowships; and, full administrative support for Center grants including CCNE, PSOC, ICBP and the Ludwig Center. Ms. Quense was hired in January 2007. She holds an MPA from Harvard and has an extensive background in non-profit and academic financial administration and administrative management. Ms. Quense reports directly to Dr. Jacks, Director of the Koch Institute, and is part of the CCSG Senior Leadership and the Executive Committee. Ms. Quense also interfaces with MIT administrative officials to ensure a cohesive relationship between the Koch Institute and the Institute. She also serves as liaison with the Howard Hughes Medical Institute. There are 20 FTEs on the HQ team. This has grown from 16 in the last renewal linked to the expansion to the Koch Institute building. Of the 20 HQ staff, support for 4 FTEs is requested from the CCSG Administrative budget. The remaining staff are covered by Institutional or other research funds. Senior Leadership: The Senior Leadership of the Koch Institute consists of the Director, Dr. Tyler Jacks, the two Associate Directors, Drs. Jacqueline Lees and K. Dane Wittrup, and the Assistant Director for Administration, Ms. Cynthia Quense. The Senior Leadership meets regularly with the other CCSG Program leaders (Drs. Amon, Bhatia, Hynes, Langer, Sharp, and Yaffe ? who is also the Director of the Koch Institute Clinical Investigator Program) as the Koch Institute Executive Committee (EC) to discuss planning issues including Membership, faculty and staff hiring, junior faculty mentoring, Core Facilities, space issues, policies, and use of Developmental Funds. All costs of Senior Leadership are covered through Institutional support.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts Institute of Technology
United States
Zip Code
Wong, Madeline Y; Doan, Ngoc Duc; DiChiara, Andrew S et al. (2018) A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production. Biochemistry 57:2814-2827
Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Tokatlian, Talar; Kulp, Daniel W; Mutafyan, Andrew A et al. (2018) Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Sci Rep 8:16527
Crowell, Laura E; Lu, Amos E; Love, Kerry R et al. (2018) On-demand manufacturing of clinical-quality biopharmaceuticals. Nat Biotechnol :
Lo, Justin H; Hao, Liangliang; Muzumdar, Mandar D et al. (2018) iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Mol Cancer Ther 17:2377-2388
Berger, Gilles; Grauwet, Korneel; Zhang, Hong et al. (2018) Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett 416:138-148
Johnson, Hannah; White, Forest M (2018) Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors. Methods Mol Biol 1711:149-164
Phillips, Angela M; Doud, Michael B; Gonzalez, Luna O et al. (2018) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife 7:
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650

Showing the most recent 10 out of 904 publications